Loading...

Mark Bounthavong

Title(s)Associate Professor Of Clinical, School of Pharmacy and Pharmaceutical Science
SchoolVc-health Sciences-schools
Address9500 Gilman Drive #
La Jolla CA 92093
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Virtual academic detailing (e-Detailing): A vital tool during the COVID-19 pandemic. J Am Pharm Assoc (2003). 2020 Jul 31. Hoffman JD, Shayegani R, Spoutz PM, Hillman AD, Smith JP, Wells DL, Popish SJ, Himstreet JE, Manning JM, Bounthavong M, Christopher MLD. PMID: 32747164.
      View in: PubMed   Mentions:    Fields:    
    2. Pharmacists on the front-line of solving a public health crisis: Increasing access to medications for opioid use disorder. J Am Pharm Assoc (2003). 2020 Mar - Apr; 60(2):297-303. Luli AJ, Bounthavong M, Watanabe JH. PMID: 31889651.
      View in: PubMed   Mentions:    Fields:    
    3. Comparison of naloxone prescribing patterns due to educational outreach conducted by full-time and part-time academic detailers at the U.S. Veterans Health Administration. J Am Pharm Assoc (2003). 2020 Jul - Aug; 60(4):639-646. Bounthavong M, Harvey MA, Kay CL, Lau MK, Wells DL, Himstreet JE, Popish SJ, Oliva EM, Christopher MLD. PMID: 31866383.
      View in: PubMed   Mentions:    Fields:    
    4. Providers' perceptions on barriers and facilitators to prescribing naloxone for patients at risk for opioid overdose after implementation of a national academic detailing program: A qualitative assessment. Res Social Adm Pharm. 2020 Aug; 16(8):1033-1040. Bounthavong M, Suh K, Christopher MLD, Veenstra DL, Basu A, Devine EB. PMID: 31706950.
      View in: PubMed   Mentions:    Fields:    
    5. Academic Detailing to Reduce Sedative-Hypnotic Prescribing in Older Veterans. J Pharm Pract. 2019 Aug 25; 897190019870949. Ragan AP, Aikens GB, Bounthavong M, Brittain K, Mirk A. PMID: 31446823.
      View in: PubMed   Mentions:    Fields:    
    6. Correction to: Cost-Effectiveness Analysis of Patiromer and Spironolactone Therapy in Heart Failure Patients with Hyperkalemia. Pharmacoeconomics. 2019 Aug; 37(8):1071. Bounthavong M, Butler J, Dolan CM, Dunn JD, Fisher KA, Oestreicher N, Pitt B, Hauptman PJ, Veenstra DL. PMID: 31089966.
      View in: PubMed   Mentions:    Fields:    
    7. Medicare Beneficiaries, Especially Unsubsidized Minorities, Struggle to Pay for Prescription Drugs: Results from the Medicare Current Beneficiary Survey. J Gen Intern Med. 2020 Apr; 35(4):1334-1336. Li M, Bounthavong M. PMID: 31342322.
      View in: PubMed   Mentions:    Fields:    
    8. Implementation evaluation of academic detailing on naloxone prescribing trends at the United States Veterans Health Administration. Health Serv Res. 2019 10; 54(5):1055-1064. Bounthavong M, Devine EB, Christopher MLD, Harvey MA, Veenstra DL, Basu A. PMID: 31313839.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    9. Impact of academic detailing on benzodiazepine use among veterans with posttraumatic stress disorder. Subst Abus. 2020; 41(1):101-109. Bounthavong M, Lau MK, Popish SJ, Kay CL, Wells DL, Himstreet JE, Harvey MA, Christopher MLD. PMID: 30870137.
      View in: PubMed   Mentions: 1     Fields:    
    10. Clinical dashboard development and use for academic detailing in the U.S. Department of Veterans Affairs. J Am Pharm Assoc (2003). 2019 Mar - Apr; 59(2S):S96-S103.e3. Lau MK, Bounthavong M, Kay CL, Harvey MA, Christopher MLD. PMID: 30713078.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    11. Comparison of rapid vs in-depth qualitative analytic methods from a process evaluation of academic detailing in the Veterans Health Administration. Implement Sci. 2019 02 01; 14(1):11. Gale RC, Wu J, Erhardt T, Bounthavong M, Reardon CM, Damschroder LJ, Midboe AM. PMID: 30709368.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    12. Cost-Effectiveness Analysis of Patiromer and Spironolactone Therapy in Heart Failure Patients with Hyperkalemia. Pharmacoeconomics. 2018 12; 36(12):1463-1473. Bounthavong M, Butler J, Dolan CM, Dunn JD, Fisher KA, Oestreicher N, Pitt B, Hauptman PJ, Veenstra DL. PMID: 30194623.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    13. Commentary on Rege et al. (2018): Naloxone reports to US poison centers highlight overdose prevention opportunities. Addiction. 2018 12; 113(12):2316-2317. Oliva EM, Bounthavong M. PMID: 30345624.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    14. Reducing Benzodiazepine Prescribing in Older Veterans: A Direct-to-Consumer Educational Brochure. Fed Pract. 2018 Sep; 35(9):36-43. Mendes MA, Smith JP, Marin JK, Bounthavong M, Lau MK, Miranda JL, Gray D, Brown M, Hauser P. PMID: 30766385.
      View in: PubMed   Mentions:
    15. Academic Detailing to Improve Opioid Safety: Implementation Lessons from a Qualitative Evaluation. Pain Med. 2018 09 01; 19(suppl_1):S46-S53. Midboe AM, Wu J, Erhardt T, Carmichael JM, Bounthavong M, Christopher MLD, Gale RC. PMID: 30203010.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    16. Emergency Medical Services Naloxone Administration: Many Unknowns and Opportunities. Ann Intern Med. 2017 12 19; 167(12):890-891. Oliva EM, Bounthavong M. PMID: 29181541.
      View in: PubMed   Mentions:    Fields:    
    17. Evaluating the Impact of a Clinical Decision Support Tool to Reduce Chronic Opioid Dose and Decrease Risk Classification in a Veteran Population. Ann Pharmacother. 2018 04; 52(4):325-331. Patel S, Carmichael JM, Taylor JM, Bounthavong M, Higgins DT. PMID: 29086587.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    18. Opioid overdose education and naloxone distribution: Development of the Veterans Health Administration's national program. J Am Pharm Assoc (2003). 2017 Mar - Apr; 57(2S):S168-S179.e4. Oliva EM, Christopher MLD, Wells D, Bounthavong M, Harvey M, Himstreet J, Emmendorfer T, Valentino M, Franchi M, Goodman F, Trafton JA. PMID: 28292502.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    19. Estimated Cost-Effectiveness, Cost Benefit, and Risk Reduction Associated with an Endocrinologist-Pharmacist Diabetes Intense Medical Management "Tune-Up" Clinic. J Manag Care Spec Pharm. 2017 Mar; 23(3):318-326. Hirsch JD, Bounthavong M, Arjmand A, Ha DR, Cadiz CL, Zimmerman A, Ourth H, Morreale AP, Edelman SV, Morello CM. PMID: 28230459.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    20. Trends in naloxone prescriptions prescribed after implementation of a National Academic Detailing Service in the Veterans Health Administration: A preliminary analysis. J Am Pharm Assoc (2003). 2017 Mar - Apr; 57(2S):S68-S72. Bounthavong M, Harvey MA, Wells DL, Popish SJ, Himstreet J, Oliva EM, Kay CL, Lau MK, Randeria-Noor PP, Phillips AG, Christopher MLD. PMID: 28089521.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    21. Relative costs of anesthesiologist prepared, hospital pharmacy prepared and outsourced anesthesia drugs. J Clin Anesth. 2017 Feb; 36:178-183. Jelacic S, Craddick K, Nair BG, Bounthavong M, Yeung K, Kusulos D, Knutson JA, Somani S, Bowdle A. PMID: 28183562.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    22. Economic evaluation of home-based telebehavioural health care compared to in-person treatment delivery for depression. J Telemed Telecare. 2018 Feb; 24(2):84-92. Bounthavong M, Pruitt LD, Smolenski DJ, Gahm GA, Bansal A, Hansen RN. PMID: 27838639.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    23. An evaluation of health care expenditures in Crohn's disease using the United States Medical Expenditure Panel Survey from 2003 to 2013. Res Social Adm Pharm. 2017 May - Jun; 13(3):530-538. Bounthavong M, Li M, Watanabe JH. PMID: 27263802.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    24. Outcome Assessments and Cost Avoidance of an Oral Chemotherapy Management Clinic. J Natl Compr Canc Netw. 2016 03; 14(3):279-85. Wong SF, Bounthavong M, Nguyen CP, Chen T. PMID: 26957614.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    25. Approach to addressing missing data for electronic medical records and pharmacy claims data research. Pharmacotherapy. 2015 Apr; 35(4):380-7. Bounthavong M, Watanabe JH, Sullivan KM. PMID: 25884526.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    26. New start versus continuing users on aripiprazole: implications for policy. Am J Manag Care. 2015 Jan 01; 21(1):e43-50. Kazerooni R, Nguyen JB, Bounthavong M, Tran MH, Madkour N. PMID: 25880267.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    27. Development and validation of PSPSQ 2.0 measuring patient satisfaction with pharmacist services. Res Social Adm Pharm. 2015 Jul-Aug; 11(4):487-98. Sakharkar P, Bounthavong M, Hirsch JD, Morello CM, Chen TC, Law AV. PMID: 25481330.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    28. Retrospective cohort study evaluating exenatide twice daily and long-acting insulin analogs in a Veterans Health Administration population with type 2 diabetes. Diabetes Metab. 2014 Sep; 40(4):284-91. Bounthavong M, Tran JN, Golshan S, Piland NF, Morello CM, Blickensderfer A, Best JH. PMID: 25059703.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    29. Implementation and preliminary outcomes of a comprehensive oral chemotherapy management clinic. Am J Health Syst Pharm. 2014 Jun 01; 71(11):960-5. Wong SF, Bounthavong M, Nguyen C, Bechtoldt K, Hernandez E. PMID: 24831001.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    30. Retrospective cohort study of anti-tumor necrosis factor agent use in a veteran population. PeerJ. 2014; 2:e385. Bounthavong M, Madkour N, Kazerooni R. PMID: 24883246.
      View in: PubMed   Mentions:
    31. A tobacco cessation treatment model using telehealth: a pilot evaluation in Veterans. J Telemed Telecare. 2014 Apr; 20(3):161-3. Chen TC, Christofferson DE, Hamlett-Berry K, Kazerooni R, Bounthavong M, Bodie L, Myers M. PMID: 24643952.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    32. Association of copayment with likelihood and level of adherence in new users of statins: a retrospective cohort study. J Manag Care Pharm. 2014 Jan; 20(1):43-50. Watanabe JH, Kazerooni R, Bounthavong M. PMID: 24372459.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    33. Ceftolozane/tazobactam: a novel antipseudomonal cephalosporin and ß-lactamase-inhibitor combination. Infect Drug Resist. 2013 Nov 29; 6:215-23. Hong MC, Hsu DI, Bounthavong M. PMID: 24348053.
      View in: PubMed   Mentions:
    34. Comparison of an intensive pharmacist-managed telephone clinic with standard of care for tobacco cessation in a veteran population. Health Promot Pract. 2014 Jul; 15(4):512-20. Chen T, Kazerooni R, Vannort EM, Nguyen K, Nguyen S, Harris J, Bounthavong M. PMID: 24231631.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    35. Association of polypharmacy and statin new-user adherence in a Veterans Health Administration population: a retrospective cohort study. Ann Pharmacother. 2013 Oct; 47(10):1253-9. Watanabe JH, Bounthavong M, Chen T, Ney JP. PMID: 24259688.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    36. Association of copayment and statin adherence stratified by socioeconomic status. Ann Pharmacother. 2013 Nov; 47(11):1463-70. Kazerooni R, Bounthavong M, Watanabe JH. PMID: 24259605.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    37. Association between statin adherence and cholesterol level reduction from baseline in a veteran population. Pharmacotherapy. 2013 Oct; 33(10):1044-52. Kazerooni R, Watanabe JH, Bounthavong M. PMID: 23744794.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    38. Revisiting the medication possession ratio threshold for adherence in lipid management. Curr Med Res Opin. 2013 Mar; 29(3):175-80. Watanabe JH, Bounthavong M, Chen T. PMID: 23320610.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    39. Cost-effectiveness of linezolid in methicillin-resistant Staphylococcus aureus skin and skin structure infections. Expert Rev Pharmacoecon Outcomes Res. 2012 Dec; 12(6):683-98. Bounthavong M, Hsu DI. PMID: 23252352.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    40. Cost utility of tumour necrosis factor-a inhibitors for rheumatoid arthritis: an application of Bayesian methods for evidence synthesis in a Markov model. Pharmacoeconomics. 2012 Jul 01; 30(7):575-93. Nguyen CM, Bounthavong M, Mendes MA, Christopher ML, Tran JN, Kazerooni R, Morreale AP. PMID: 22640174.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    41. Cost-effectiveness of cytochrome P450 2C19 genotype screening for selection of antiplatelet therapy with clopidogrel or prasugrel: a commentary. Pharmacotherapy. 2012 Jun; 32(6):e170; discussion e170-1. Madkour N, Bounthavong M. PMID: 22674743.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    42. Retrospective evaluation of inpatient celecoxib use after total hip and knee arthroplasty at a Veterans Affairs Medical Center. J Arthroplasty. 2012 Jun; 27(6):1033-40. Kazerooni R, Bounthavong M, Tran JN, Boggie DT, Meyer RS. PMID: 22386610.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    43. Cost-effectiveness analysis of linezolid, daptomycin, and vancomycin in methicillin-resistant Staphylococcus aureus: complicated skin and skin structure infection using Bayesian methods for evidence synthesis. Value Health. 2011 Jul-Aug; 14(5):631-9. Bounthavong M, Zargarzadeh A, Hsu DI, Vanness DJ. PMID: 21839399.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCells
    44. A monograph assignment as an integrative application of evidence-based medicine and pharmacoeconomic principles. Am J Pharm Educ. 2011 Feb 10; 75(1):1. Law AV, Jackevicius CA, Bounthavong M. PMID: 21451753.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    45. Cost-utility analysis of bevacizumab versus ranibizumab in neovascular age-related macular degeneration using a Markov model. J Eval Clin Pract. 2012 Apr; 18(2):247-55. Patel JJ, Mendes MA, Bounthavong M, Christopher ML, Boggie D, Morreale AP. PMID: 20846318.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    46. Measuring patient satisfaction in the pharmacy specialty immunization clinic: a pharmacist-run Immunization Clinic at the Veterans Affairs San Diego Healthcare System. Int J Pharm Pract. 2010 Apr; 18(2):100-7. Bounthavong M, Christopher ML, Mendes MA, Foster EB, Johns ST, Lim L, Rubin LM, Patel JJ, Stewart AG. PMID: 20441119.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    47. Cost-effectiveness analysis of intravenous levetiracetam versus intravenous phenytoin for early onset seizure prophylaxis after neurosurgery and traumatic brain injury. Clinicoecon Outcomes Res. 2010; 2:15-23. Kazerooni R, Bounthavong M. PMID: 21935311.
      View in: PubMed   Mentions:
    48. Efficacy and safety of linezolid in methicillin-resistant Staphylococcus aureus (MRSA) complicated skin and soft tissue infection (cSSTI): a meta-analysis. Curr Med Res Opin. 2010 Feb; 26(2):407-21. Bounthavong M, Hsu DI. PMID: 20001574.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCells
    49. Implementing a comprehensive, 24-hour emergency department pharmacy program. Am J Health Syst Pharm. 2009 Nov 01; 66(21):1943-7. Aldridge VE, Park HK, Bounthavong M, Morreale AP. PMID: 19850790.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    50. Cost-effectiveness analysis of linezolid vs. vancomycin in treating methicillin-resistant Staphylococcus aureus complicated skin and soft tissue infections using a decision analytic model. Int J Clin Pract. 2009 Mar; 63(3):376-86. Bounthavong M, Hsu DI, Okamoto MP. PMID: 19222624.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCells
    51. Identifying health-related quality of life (HRQL) domains for multiple chronic conditions (diabetes, hypertension and dyslipidemia): patient and provider perspectives. J Eval Clin Pract. 2008 Dec; 14(6):1002-11. Bounthavong M, Law AV. PMID: 18759755.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    52. Decision analysis model evaluating the cost-effectiveness of risperidone, olanzapine and haloperidol in the treatment of schizophrenia. J Eval Clin Pract. 2007 Jun; 13(3):453-60. Bounthavong M, Okamoto MP. PMID: 17518814.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    Mark's Networks
    Concepts (238)
    Derived automatically from this person's publications.
    _
    Co-Authors (7)
    People in Profiles who have published with this person.
    _
    Similar People (60)
    People who share similar concepts with this person.
    _
    Same Department
    Search Department
    _